National Taiwan University_ Factor 9 treatment on Hemophilia type B patient

2010, Jun., 10 Taiwan National pharmaceutical & Biotech project announced sponsored technology regarding engineered high potent (rather than long circulation) factor 9 for treatment of hemophilia.